Study suggests rates of thrombocytopenia and VTE increase after Pfizer The ‘interesting’ research contains a number of clinical takeaways for general practice, but shows no clear link to TTS, a GP says.
Australian authorities update side effect advice on AstraZeneca vaccine The ATAGI release confirms most over-50s can receive the vaccine, and that the rare blood clotting linked to AstraZeneca can be treated effectively.
‘No change’ in risk profile with second blood clot case linked to AstraZeneca Two cases of clotting in 700,000 administered doses does not indicate an increased level of risk, experts have said.
ATAGI issues GPs with guidance for clotting condition ‘likely’ linked to COVID vaccine The national advisory body is urging vaccine providers to be aware of post-vaccination warning signs, including new onset of severe persistent headache that is not settling with analgesia.